Literature DB >> 2986009

Identification of the human analogue of a regulator that induces differentiation in murine leukaemic cells.

N A Nicola, C G Begley, D Metcalf.   

Abstract

We have recently purified murine granulocyte colony-stimulating factor (G-CSF), a regulatory glycoprotein which stimulates granulocyte colony formation from committed murine precursor cells in semi-solid agar cultures. G-CSF is one of a family of colony-stimulating factors that regulate the growth and differentiation of granulocytes and macrophages. While the other murine CSFs (granulocyte-macrophage (GM)-CSF, macrophage (M)-CSF and multi-CSF) show little or no differentiation-inducing activity on murine myelomonocytic leukaemia cell lines, G-CSF (or MGI-2(6)) is able to induce the production of terminally differentiated cells from WEHI-3B and other myeloid leukaemia cell lines. More importantly, G-CSF-containing materials suppress the self-renewal of myeloid leukaemia stem cells in vitro and the leukaemogenicity of treated myeloid leukaemic cells in vivo. It is important to identify the human analogue of murine G-CSF so that its effectiveness on human myeloid leukaemia cells can be assessed. Here we show that an analogue of G-CSF does exist among the CSFs produced by human cells and that the murine and human molecules show almost complete biological and receptor-binding cross-reactivities to normal and leukaemic murine or human cells. The human G-CSF analogue is identified as a species of CSF that we have previously described as CSF-beta.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2986009     DOI: 10.1038/314625a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  36 in total

1.  Recombinant filgrastim (BK0023) pharmacodynamics and pharmacokinetics after single and multiple escalating doses in an equivalence study in healthy men.

Authors:  Andrea F D Di Stefano; Gaia Spinetti; Antonio Rusca; Milko M Radicioni; Luca Loprete; Domenica M G Lamparelli; Jutta Michael Hepp; Davide Crobu; Rodolfo Schrepfer; Giancarlo Tonon
Journal:  Clin Drug Investig       Date:  2015-09       Impact factor: 2.859

2.  Alternatively spliced, truncated GCSF receptor promotes leukemogenic properties and sensitivity to JAK inhibition.

Authors:  H M Mehta; M Futami; T Glaubach; D W Lee; J R Andolina; Q Yang; Z Whichard; M Quinn; H F Lu; W M Kao; B Przychodzen; C A Sarkar; A Minella; J P Maciejewski; S J Corey
Journal:  Leukemia       Date:  2013-10-30       Impact factor: 11.528

3.  The zebrafish granulocyte colony-stimulating factors (Gcsfs): 2 paralogous cytokines and their roles in hematopoietic development and maintenance.

Authors:  David L Stachura; Ondrej Svoboda; Clyde A Campbell; Raquel Espín-Palazón; Ryan P Lau; Leonard I Zon; Petr Bartunek; David Traver
Journal:  Blood       Date:  2013-10-15       Impact factor: 22.113

4.  Hematopoietic growth factors.

Authors:  C A Sieff
Journal:  J Clin Invest       Date:  1987-06       Impact factor: 14.808

Review 5.  Colony-stimulating factors in the pathogenesis and treatment of disease.

Authors:  D J Williamson; C G Begley
Journal:  Postgrad Med J       Date:  1987-12       Impact factor: 2.401

6.  The detection and initial characterization of colony-stimulating factors in synovial fluid.

Authors:  D J Williamson; C G Begley; M A Vadas; D Metcalf
Journal:  Clin Exp Immunol       Date:  1988-04       Impact factor: 4.330

7.  Granulocyte colony-stimulating factor (G-CSF) as an adjunct to induction chemotherapy of adult acute lymphoblastic leukemia (ALL).

Authors:  R Scherrer; K Geissler; P A Kyrle; H Gisslinger; U Jäger; P Bettelheim; K Laczika; G Locker; C Scholten; C Sillaber
Journal:  Ann Hematol       Date:  1993-06       Impact factor: 3.673

8.  G-CSF down-regulation of CXCR4 expression identified as a mechanism for mobilization of myeloid cells.

Authors:  Hyun Kyung Kim; Maria De La Luz Sierra; Cassin Kimmel Williams; A Virginia Gulino; Giovanna Tosato
Journal:  Blood       Date:  2006-03-14       Impact factor: 22.113

9.  Granulocyte-colony stimulating factor for stroke treatment: mechanisms of action and efficacy in preclinical studies.

Authors:  Jens Minnerup; Sevgi Sevimli; Wolf-Rüdiger Schäbitz
Journal:  Exp Transl Stroke Med       Date:  2009-10-21

10.  Hochuekkito, a Kampo (Traditional Japanese Herbal) Medicine, and its Polysaccharide Portion Stimulate G-CSF Secretion from Intestinal Epithelial Cells.

Authors:  Tsukasa Matsumoto; Michiyo Moriya; Hiroaki Kiyohara; Yoshiaki Tabuchi; Haruki Yamada
Journal:  Evid Based Complement Alternat Med       Date:  2008-02-27       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.